SlideShare ist ein Scribd-Unternehmen logo
1 von 55
PHARMACOTHERAPY
OF CORNEAL ULCER
Presented by-
Dr. Rajesh A Kamtane,
3rd year PG,
Dept. of Pharmacology,
MIMS
Ulcerative Keratitis (corneal ulcer) is seen in-
A.Infective Keratitis---Bacterial, Viral or Mycotic
corneal ulcer
B.Protozoal Keratitis---Acanthamoeba Keratitis
C.Allergic Keratitis---Phylectenular, Vernal or
Atopic Keratitis
D.Peripheral Ulcerative Keratitis---associated with
connective tissue disorders, Mooren’s Ulcer or
Rosacea Keratitis
E. Trophic Corneal Ulcers---Neurotrophic or
Exposure Keratopathy
Bacterial Corneal Ulcer
Common bacteria associated with corneal ulceration are-
--Staphylococcus aureus, Streptococcus
pneumoniae, E.coli, Proteus, Klebsiella, Pseudomonas,
N. gonorrhoea, N. meningitidis, C. diptheriae
Specific treatment-
Topical antibiotics-
Initial therapy (before C & S reports are available)
should be combination therapy to cover both gram
positive and negative organisms.
Any of the following 2 drugs can be instilled---
Fortified cefazolin + fortified tobramycin
or
Fortified vancomycin + one of the commercially
available fluoroquinolone eye drops (0.3 % cipro/
oflox/ gati or 0.5% moxi)
Frequency of instillation-
The chosen two drugs should be instilled alternately as
below—
1 hourly round the clock for first 48 hours.
2 hourly during day and 4 hourly at night till healing is
ensured.
4 hourly till healing occurs.
Once favorable response is obtained, fortified drops can
be substituted by commercially available eye drops.
Subsequent therapy-
No need to change initial antibiotics if response is good.
If response is poor, immediately change the antibiotics
as per C & S reports.
Systemic antibiotics-
Usually not required.
However, a cephalosporin or an aminoglycoside or oral
ciprofloxacin (750 mg BD) may be given in fulminating
cases with perforation or when sclera is also involved.
Non-Specific treatment:
Cycloplegic drugs.
Topical/ Systemic NSAIDs to relive pain and edema.
Vitamins (A, B- complex & C) help in early healing of
ulcer.
Non-Specific treatment…..
Secondary glaucoma can occur due to fibrinous exudates
blocking the angle of anterior chamber. Anti-glaucoma
drugs can be given to lower IOP (details in further slides).
Topical steroids in selected cases. E.g. marginal catarrhal
ulcer which is caused by hypersensitivity reaction to
Staphylococcal toxins (details in further slides).
Mycotic Corneal Ulcer
In recent years its incidence is increased due to injudicious use
of antibiotics and steroids.
Specific treatment
Topical antifungals:
Natamycin (5%), Amphotericin B and either Fluconazole
(0.2%) or miconazole or voriconazole (10% )eye drops to be
instilled one hourly round the clock, then taper slowly over 6-
8 weeks. These are effective against Aspergillus and Fusarium.
Nystatin (3.5%) eye ointment, five times a day is effective
against Candida.
Systemic antifungal drugs may be required for severe
cases of fungal keratitis. Tablet fluconazole or
ketoconazole may be given for 2-3 weeks.
Non-specific treatment-
NSAIDs’, cycloplegics, vitamins
Viral Corneal Ulcer
Herpes Simplex Keratitis
Specific treatment:
Antiviral drugs are first choice presently.
Usually after 4 days of therapy, lesion starts healing
which is completed by 10 days. After healing, taper
the drug and withdraw in 5 days.
If after 7 days of initial therapy, there is no response,
it means that virus is resistant to this drug. Hence
change the drug and / or do mechanical debridement.
Commonly used antiviral drugs are as follows-
Acyclovir –
1. 3% ointment, 5 times a day until ulcer heals
and then 3 times a day for 5 days.
2. It is least toxic and most commonly used
antiviral drug.
Ganciclovir -
1. 0.15% gel, 5 times a day until ulcer heals
and then 3 times a day for 5 days.
2. It is more toxic than acyclovir.
Triflurothymidine
1% drops, 2 hourly until ulcer heals and then 4 times a
day for 5 days.
Vidarabine
3% ointment, 5 times a day until ulcer heals and then
3 times a day for 5 days.
Systemic antiviral drugs for a period of 10 to 21 days
are used in recurrent and acute cases.
Tb. Acyclovir 400 mg BD/ TID
Tb. Famcyclovir 250 mg BD
Tb. Valacyclovir 500 mg BD
Non specific treatment-
Same as earlier.
Herpes Zoster Opthalmicus
Systemic therapy for Herpes Zoster
Oral antiviral drugs-
Tb. Acyclovir 800 mg 5 times a day for 10 days or
Tb. Valacyclovir 500 mg TID
Analgesics-
Pain during first 2 weeks of an attack is very severe and
should be treated by combination of mephenamic acid and
paracetamol or pentazocin or even pethidine (when very
severe).
Systemic Steroids-
They inhibit development of post herpetic neuralgia when
given in high doses. However, the risk of high doses of
steroids in elders should be considered.
They are commonly recommended in cases developing
neurological complications such as third nerve palsy and
optic neuritis.
Cimetidine 300 mg QID for 2-3 weeks reduces pain and
pruritis in acute zoster, by histamine blockade.
Amitriptyline to relieve depression in acute phase.
Local therapy for Herpes Zoster
1. For skin lesions-
Antibiotic- steroid ointment or lotions-- three times a day till
skin lesions heal.
2. For zoster keratitis-
• Topical steroid eye drops 4 times a day.
• Cycloplegics such as cyclopentolate eye drops or atropine
eye ointment OD.
• Topical acyclovir 3% eye ointment, 5 times a day for 2
weeks.
3. For secondary infections-
Topical antibiotics
4. For secondary glaucoma-
0.5% timolol or betaxolol eye drops BD and Tb. Acetazolamide
250 mg QID.
5. For mucous plaques-
Topical mucolytics like acetyl cysteine 5 to 10%, TID.
6. For persistent epithelial defects-
Lubricating artificial tear drops.
Protozoal Keratitis
Acanthamoeba keratitis
Specific treatment:
Topical antiamoebic agents include-
Diamidines: propamidine isethionate
(0.1%), hexamidine (0.1%)
Biguanides: polyhexamethylene biguanide
(0.02%), chlorhexidine (0.02%)
Aminoglycosides: neomycin, paromycin
Imidazoles: clotrimazole and miconazole
Multiple drug therapy is required for 3-4 months for
early epithelial lesions and 6-12 months for stromal
lesions.
Allergic Keratitis
Local therapy
1. Vasoconstrictors like adrenaline, ephedrine and
naphazoline.
2. Topical steroids—
Their use should be minimized as much as possible,
because they frequently cause steroid induced glaucoma.
Commonly used steroids are fluorometholone, medrysone,
betamethasone or dexamethasone. First two are safest of
all these.
3. Mast cell stabilizers such as sodium chromoglycate (2%)
drops 4-5 times a day.
4. Topical antihistaminics-
Azelastine eye drops
5. Acetyl cysteine (0.5%) has mucolytic properties and is
useful in treating early plaque formation.
6. Topical cyclosporine (1%) drops effective in severe
unresponsive cases.
Systemic therapy-
Oral antihistaminics and oral steroids in severe cases.
Peripheral ulcerative keratitis associated with
connective tissue disorders, Mooren’s Ulcer
Topical medication with antibiotics,
cycloplegics, steroids, lubricating drops.
Systemic medication includes
immunosuppresants (steroids, cyclosporine,
cyclophosphamide), doxycycline and oral
vitamin C.
Rosacea Keratitis
Topical treatment with steroids, but recurrences are very
common.
Systemic therapy—
Most essential and effective treatment is long course of
systemic tetracycline (250 mg QID for 3 weeks, TID for 3
weeks, BD for 3 weeks and OD for 3 months).
Common ocular therapeutics
Antibacterial agents
Sulphonamides:
1. Bacteriostatic.
2. Act by inhibiting folic acid synthesis in susceptible
microorganisms by competing with PABA which is
essential for bacterial cell nutrition.
3. Used in treatment of chlamydial infections.
Beta lactam antibiotics:
Two important groups included are penicillins and
cephalosporins.
All of them act by interfering with synthesis of bacterial cell
wall.
Penicillins-
Commonly used preparations are –
Benzyl penicillin, procaine penicilln, ampicillin, amoxycillin.
Methicillin, cloxacillin, flucloxacillin, carbenicillin---these are
penicillinase resistant, useful in infections caused by staph,
proteus, pseudomonas and coliform organisms.
Cephalosporins-
First generation (narrow spectrum)-
1. Active against gram positive cocci, hence useful against
staphylococcus.
2. Includes---cefazolin, cephradine, cephalexin, cephadroxyl
Second generation (intermediate spectrum)-
1. These have antistaphylococcal activity and are also
effective against certain gram negative organisms.
2. These include—cefuroxime, cefoxitin, cefamandole.
Third generation (wide spectrum)-
1. Mainly effective against gram negative organisms.
2. These include—cefotaxime, cefixime, cefotetan
Aminoglycosides-
Bactericidal.
Primarily active against gram negative organisms.
These are ototoxic and nephrotoxic.
Aminoglycosides……..
Commonly used preparations are—
Gentamicin-
1. Most commonly used aminoglycoside for acute infections,
broader spectrum of action, effective against
Pseudomonas aeruginosa.
2. Topically , it is used as 0.3% eye drops.
Tobramycin-
1. More active against Pseudomonas and Proteus as
compared to gentamicin.
2. Topically, it is used as 1% eye drops.
Aminoglycosides……
Amikacin-
It is recommended as reserve drug for hospital acquired
infections with gram negative bacilli, where gentamicin
resistance is increasing.
Neomycin and Framycetin-
1. Wide spectrum of activity.
2. Active against most gram negative and some gram positive
cocci.
3. Used only topically, due to high systemic toxicity.
Tetracyclines and Chloramphenicol-
1. Broad spectrum bacteriostatic agents.
2. Active against gram positive, gram negative organisms as
well as some fungi, Rickettsiae and Chlamydiae.
3. Topically used as 0.5 % eye drops.
Polypeptides-
1. Bactericidal.
2. Includes polymyxin B, bacitracin, colistin.
3. Polymyxin B and colistin—active against most gram
negative bacteria, notably Pseudomonas.
4. Neosporin (neomycin-polymyxin-bacitracin)—broad
spectrum antimicrobial, but has a disadvantage of high
incidence of sensitivity due to neomycin.
Fluoroquinolones-
1. Broad spectrum of activity against gram positive and gram
negative organisms.
2. Bactericidal drugs. Inhibit bacterial DNA synthesis.
Commonly used are—
1. First generation—cipro, norfloxacin
2. Second generation– ofloxacin, lomefloxacin, pefloxacin.
3. Third generation– sparfloxacin
4. Fourth generation—gati, moxifloxacin
Ocular antifungal agents
Polyene antifungals-
1. Mainstay of antifungal therapy.
2. MOA—work by binding to the sterol groups in fungal cell
membrane, making them impermeable. This leads to
lethal imbalance in cell contents.
3. These include—
Nystatin, natamycin, amphotericin B.
Ocular antifungal agents….
Imidazole antifungal drugs-
These include clotrimazole, econazole, fluconazole,
miconazole, itraconazole.
Other antifungals-
Flucytosine
Silver sulfadiazine—highly effective against Aspergillus
and Fusarium species.
Anti-glaucoma drugs for treating
secondary glaucoma
Timolol, Betaxolol-
Class---beta blockers
MOA---they block beta 2 receptors in the ciliary processess,
resulting in decreased aqueous production, thus lowering the
IOP.
These drugs should be used cautiously in patients with
bronchial asthma, emphysema, COPD, heart blocks, CCF and
cardiomyopathy.
Timolol, betaxolol…….
Ocular side effects-
Burning sensation, hyperemia, superficial punctate
keratopathy, corneal anesthesia.
Systemic side effects-
CVS---result from blockade of beta 1 receptors.
These include—bradycardia, arrhythmias, heart
failure, syncope.
RS---result from blockade of beta 2 receptors.
These include—brnchospasm and airway
obstruction, especially in asthmatics.
Anti-glaucoma drugs for
treating secondary
glaucoma
Timolol-
1. It is non selective beta 1 (cardiac) and beta 2 (smooth
muscles, respiratory tract) blocker.
2. Available as 0.25 and 0.5% eye drops.
3. Its action starts within 30 minutes, peak reaches in 2
hours and effects last up to 24 hours. Hence, used once or
twice daily.
Anti-glaucoma drugs for
treating secondary glaucoma
Timolol…..
4. The phenomenon of “short term escape” and “long term
drift” is seen with timolol.
“Short term escape” implies marked initial fall in IOP, followed
by a transient rise with continued moderate fall in IOP.
“Long term drift” implies slow rise in IOP in patients who
were well controlled with many months of therapy.
Anti-glaucoma drugs for
treating secondary
glaucoma
Betaxolol-
1. Is a cardioselective beta blocker, has 10 times more
affinity for beta 1 receptors than beta 2 receptors.
Hence, can be safely used in patients prone to attack of
bronchial asthma; advantage over timolol.
2. Available as 0.5 % and 0.25% suspension, is used twice
daily.
3. Action starts within 30 min, reaches peak in 2 hours and
lasts for 12 hours.
4. Slightly less effective than timolol in lowering IOP.
Anti-glaucoma drugs for
treating secondary glaucoma
Anti-glaucoma drugs for
treating secondary glaucomaAcetazolamide-
1. Is a carbonic anhydrase inhibitor.
2. Lowers IOP by reducing formation of aqueous humour.
3. Used as additive therapy for short term in management of
all types of acute and chronic glaucomas.
4. Side effects—paresthesias, urinary frequency, serum
electrolyte imbalance, abdominal discomfort, nausea,
diarrhoea.
Anti-glaucoma drugs for
treating secondary glaucomaAcetazolamide….
4. Available as tablets, capsules and injection for i.v. use.
250 mg tablet is used 6 hourly.
5. Action starts within one hour, reaches peak in 4 hours and
lasts for 6-8 hours.
Other carbonic anhydrase inhibitors—
Dorzolamide, Brinzolamide—can be used topically.
Anti-glaucoma drugs for
treating secondary glaucomaMannitol, Glycerol-
1. These are hyperosmotic agents, administered
systemically.
2. Used as additive therapy for rapidly lowering IOP in
emergency situations.
3. MOA– they increase the plasma tonicity. Thus, osmotic
gradient created between blood and vitreous draws
sufficient water out of the eyeball, thereby lowering IOP.
Anti-glaucoma drugs for
treating secondary glaucomaGlycerol-
1. Dose-1 to 1.5 gm/kg
2. Action starts in 10 minutes, peaks in 30 minutes and lasts
for about 5-6 hours.
3. It is metabolised to glucose in the body, hence repeated
use is not recommended in diabetics.
Anti-glaucoma drugs for
treating secondary glaucomaMannitol-
1. Dose-1-2 gm/kg
2. Administered very rapidly over 20-30 minutes.
3. Action peaks in 30 minutes and lasts for about 6 hours.
4. It doesn’t enter glucose metabolism, hence safe in
diabetics.
Corticosteroids
They have potent anti-inflammatory, anti-allergic and anti-
fibrotic actions.
Short acting-
Hydrocortisone, cortisone, prednisolone,
methylprednisolone, prednisone.
Intermediate acting-
Triamcinolone, fluprednisolone
Long acting-
Dexamethasone, betamethasone.
Corticosteroids …….
Commonly used topical preparations are cortisone
acetate, hydrocortisone, dexamethasone, betamethas
one, medryson, fluromethalone, loteprednol.
Commonly used systemic preparations are –
Prednisolone—5 / 10 mg tablet,
Dexamethasone– 0.5 mg tablet,
Betamethasone– 0.5 / 1 mg tablet.
Corticosteroids …….
Side effects-
Injudicious use of topical steroids can cause
glaucoma, cataract, activation of infection (if given in
herpertic, fungal or bacterial keratitis), dry eye, ptosis.
Misuse of systemic steroids can cause ocular side effects as
mentioned above and systemic side effects such as peptic
ulcer, HTN, osteoporosis, worsening of DM, cushingoid state
and reactivation of tuberculosis and other infections.
Non steroidal anti-inflammatory drugs
(NSAIDs)
They have anti-inflammatory, analgesic and antipyretic
actions.
MOA– act by irreversibly blocking COX enzyme, thus inhibiting
PG synthesis. Also block other local mediators of
inflammatory response.
Non steroidal anti-inflammatory drugs (NSAIDs)…………
Topical opthalmic NSAIDs preparations available are-
1. Indomethacin 0.1 % suspension
2. Flurbiprofen 0.3 % eye drops
3. Ketorolac 0.5 % eye drops
4. Diclofenac 0.1% eye drops
5. Bromefenac 0.09% eye drops
6. Nepafenac 0.1 % eye drops
Systemically used NSAIDs-
Paracetamol, diclofenac, acelcofenac, ketorolac, ibuprofen
flurbiprofen, naproxen, mefenamic acid, etc.
Cycloplegics
These are the drugs which cause paralysis of accommodation
and dilatation of the pupil.
Commonly used drug is atropine sulfate 1% eye ointment or
drops instilled 2-3 times a day.
In case of atropine allergy, other cycloplegics like 2%
homatropine or 1% cyclopentolate (short acting) eye drops
may be instilled 3-4 times/ day.
Alternatively for more cycloplegic effect, a subconjunctival
injection of 0.25 ml mydricain (mixture of
atropine, adrenaline and procaine) can be given.
Cycloplegics……
Mode of action of atropine-
1. Gives comfort and rest to the eye by relieving spasm of iris
sphincter and ciliary muscle.
2. Prevents formation of synechiae and may break already
formed synechiae.
3. Reduces exudation by decreasing hyperemia and vascular
permeability.
4. Increases blood supply to anterior uvea by relieving
pressure on anterior ciliary arteries. As a result more
antibodies reach the target tissue and more toxins are
absorbed.
Thank you

Weitere ähnliche Inhalte

Was ist angesagt?

Macular function tests
Macular function testsMacular function tests
Macular function tests
abubaker77
 

Was ist angesagt? (20)

Ptosis workup
Ptosis workupPtosis workup
Ptosis workup
 
Newer drugs in Glaucoma Mangement
Newer drugs in Glaucoma MangementNewer drugs in Glaucoma Mangement
Newer drugs in Glaucoma Mangement
 
Gonioscopy presentation
Gonioscopy presentationGonioscopy presentation
Gonioscopy presentation
 
Macular function tests
Macular function testsMacular function tests
Macular function tests
 
Viral keratitis
Viral keratitisViral keratitis
Viral keratitis
 
Antifungal Agents in Ophthalmology
Antifungal Agents in OphthalmologyAntifungal Agents in Ophthalmology
Antifungal Agents in Ophthalmology
 
herpes simplex ocular diseases
herpes simplex ocular diseasesherpes simplex ocular diseases
herpes simplex ocular diseases
 
Bandage Contact Lens
Bandage Contact LensBandage Contact Lens
Bandage Contact Lens
 
Anisometropia
AnisometropiaAnisometropia
Anisometropia
 
Entropion
EntropionEntropion
Entropion
 
Bacterial keratitis
Bacterial keratitisBacterial keratitis
Bacterial keratitis
 
Corneal Allograft Rejection
Corneal Allograft RejectionCorneal Allograft Rejection
Corneal Allograft Rejection
 
Vitreous
VitreousVitreous
Vitreous
 
Intravitreal injection
Intravitreal injectionIntravitreal injection
Intravitreal injection
 
Diseases of conjunctiva
Diseases of conjunctivaDiseases of conjunctiva
Diseases of conjunctiva
 
Cycloplegic agents & cyclorefraction
Cycloplegic agents & cyclorefractionCycloplegic agents & cyclorefraction
Cycloplegic agents & cyclorefraction
 
Keratoplasty
KeratoplastyKeratoplasty
Keratoplasty
 
Pathological Myopia.pptx
Pathological Myopia.pptxPathological Myopia.pptx
Pathological Myopia.pptx
 
Anatomy of macula
Anatomy of maculaAnatomy of macula
Anatomy of macula
 
Pterygium and its management
Pterygium and its managementPterygium and its management
Pterygium and its management
 

Andere mochten auch (12)

Anatomy of uvea
Anatomy of uveaAnatomy of uvea
Anatomy of uvea
 
interstitial Keratitis
interstitial Keratitisinterstitial Keratitis
interstitial Keratitis
 
Vernal keratoconjunctivitis ophthalmology
Vernal keratoconjunctivitis ophthalmology Vernal keratoconjunctivitis ophthalmology
Vernal keratoconjunctivitis ophthalmology
 
Phlyctenular Keratitis
Phlyctenular KeratitisPhlyctenular Keratitis
Phlyctenular Keratitis
 
Cornea
CorneaCornea
Cornea
 
Uvea
UveaUvea
Uvea
 
Non ulcerative keratitis
Non ulcerative keratitisNon ulcerative keratitis
Non ulcerative keratitis
 
Acanthamoeba keratitis
Acanthamoeba keratitisAcanthamoeba keratitis
Acanthamoeba keratitis
 
Non-Infectious keratitis
Non-Infectious keratitisNon-Infectious keratitis
Non-Infectious keratitis
 
Intermediate uveitis
Intermediate uveitisIntermediate uveitis
Intermediate uveitis
 
Antifungal drugs-Antibiotics
Antifungal drugs-AntibioticsAntifungal drugs-Antibiotics
Antifungal drugs-Antibiotics
 
Antifungal drugs
Antifungal drugs Antifungal drugs
Antifungal drugs
 

Ähnlich wie Pharmacotherapy of corneal ulcer

Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics) Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)
Iyad Abou Rabii
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)
Iyad Abou Rabii
 

Ähnlich wie Pharmacotherapy of corneal ulcer (20)

Recent Advances in Treatment of Uveitis
Recent Advances in Treatment of UveitisRecent Advances in Treatment of Uveitis
Recent Advances in Treatment of Uveitis
 
Basics of Antimicrobial Drugs
Basics of Antimicrobial DrugsBasics of Antimicrobial Drugs
Basics of Antimicrobial Drugs
 
Antimicrobail agents-Mr. panneh
Antimicrobail agents-Mr. pannehAntimicrobail agents-Mr. panneh
Antimicrobail agents-Mr. panneh
 
Antibiotic selection /certified fixed orthodontic courses by Indian dental ...
Antibiotic selection   /certified fixed orthodontic courses by Indian dental ...Antibiotic selection   /certified fixed orthodontic courses by Indian dental ...
Antibiotic selection /certified fixed orthodontic courses by Indian dental ...
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics) Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)
 
classaminoglycosides2-150525094713-lva1-app6891.pdf
classaminoglycosides2-150525094713-lva1-app6891.pdfclassaminoglycosides2-150525094713-lva1-app6891.pdf
classaminoglycosides2-150525094713-lva1-app6891.pdf
 
Class aminoglycosides 2
Class aminoglycosides 2Class aminoglycosides 2
Class aminoglycosides 2
 
Anti tubercular drug
Anti tubercular drugAnti tubercular drug
Anti tubercular drug
 
Psi 2
Psi 2Psi 2
Psi 2
 
Psi 2
Psi 2Psi 2
Psi 2
 
Psi 2
Psi 2Psi 2
Psi 2
 
Antifungal drugs
Antifungal drugs Antifungal drugs
Antifungal drugs
 
Antibiotics in ophthalmology
Antibiotics in ophthalmologyAntibiotics in ophthalmology
Antibiotics in ophthalmology
 
Antibiotics in Periodontics
Antibiotics in PeriodonticsAntibiotics in Periodontics
Antibiotics in Periodontics
 
ANTIBACTERIAL DRUGS.pdfbbdbbdndbdnsjdbdjbdj
ANTIBACTERIAL DRUGS.pdfbbdbbdndbdnsjdbdjbdjANTIBACTERIAL DRUGS.pdfbbdbbdndbdnsjdbdjbdj
ANTIBACTERIAL DRUGS.pdfbbdbbdndbdnsjdbdjbdj
 
Antifungaldrugs
AntifungaldrugsAntifungaldrugs
Antifungaldrugs
 
antibiotics.ppt
antibiotics.pptantibiotics.ppt
antibiotics.ppt
 
11.Chemotherapy.pptx
11.Chemotherapy.pptx11.Chemotherapy.pptx
11.Chemotherapy.pptx
 
Antibiotics on pediatrics part 2
Antibiotics on pediatrics part 2Antibiotics on pediatrics part 2
Antibiotics on pediatrics part 2
 

Kürzlich hochgeladen

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 

Kürzlich hochgeladen (20)

SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 

Pharmacotherapy of corneal ulcer

  • 1. PHARMACOTHERAPY OF CORNEAL ULCER Presented by- Dr. Rajesh A Kamtane, 3rd year PG, Dept. of Pharmacology, MIMS
  • 2. Ulcerative Keratitis (corneal ulcer) is seen in- A.Infective Keratitis---Bacterial, Viral or Mycotic corneal ulcer B.Protozoal Keratitis---Acanthamoeba Keratitis C.Allergic Keratitis---Phylectenular, Vernal or Atopic Keratitis D.Peripheral Ulcerative Keratitis---associated with connective tissue disorders, Mooren’s Ulcer or Rosacea Keratitis
  • 3. E. Trophic Corneal Ulcers---Neurotrophic or Exposure Keratopathy
  • 4. Bacterial Corneal Ulcer Common bacteria associated with corneal ulceration are- --Staphylococcus aureus, Streptococcus pneumoniae, E.coli, Proteus, Klebsiella, Pseudomonas, N. gonorrhoea, N. meningitidis, C. diptheriae Specific treatment- Topical antibiotics- Initial therapy (before C & S reports are available) should be combination therapy to cover both gram positive and negative organisms.
  • 5. Any of the following 2 drugs can be instilled--- Fortified cefazolin + fortified tobramycin or Fortified vancomycin + one of the commercially available fluoroquinolone eye drops (0.3 % cipro/ oflox/ gati or 0.5% moxi)
  • 6. Frequency of instillation- The chosen two drugs should be instilled alternately as below— 1 hourly round the clock for first 48 hours. 2 hourly during day and 4 hourly at night till healing is ensured. 4 hourly till healing occurs. Once favorable response is obtained, fortified drops can be substituted by commercially available eye drops.
  • 7. Subsequent therapy- No need to change initial antibiotics if response is good. If response is poor, immediately change the antibiotics as per C & S reports. Systemic antibiotics- Usually not required. However, a cephalosporin or an aminoglycoside or oral ciprofloxacin (750 mg BD) may be given in fulminating cases with perforation or when sclera is also involved.
  • 8. Non-Specific treatment: Cycloplegic drugs. Topical/ Systemic NSAIDs to relive pain and edema. Vitamins (A, B- complex & C) help in early healing of ulcer.
  • 9. Non-Specific treatment….. Secondary glaucoma can occur due to fibrinous exudates blocking the angle of anterior chamber. Anti-glaucoma drugs can be given to lower IOP (details in further slides). Topical steroids in selected cases. E.g. marginal catarrhal ulcer which is caused by hypersensitivity reaction to Staphylococcal toxins (details in further slides).
  • 10. Mycotic Corneal Ulcer In recent years its incidence is increased due to injudicious use of antibiotics and steroids. Specific treatment Topical antifungals: Natamycin (5%), Amphotericin B and either Fluconazole (0.2%) or miconazole or voriconazole (10% )eye drops to be instilled one hourly round the clock, then taper slowly over 6- 8 weeks. These are effective against Aspergillus and Fusarium. Nystatin (3.5%) eye ointment, five times a day is effective against Candida.
  • 11. Systemic antifungal drugs may be required for severe cases of fungal keratitis. Tablet fluconazole or ketoconazole may be given for 2-3 weeks. Non-specific treatment- NSAIDs’, cycloplegics, vitamins
  • 12. Viral Corneal Ulcer Herpes Simplex Keratitis Specific treatment: Antiviral drugs are first choice presently. Usually after 4 days of therapy, lesion starts healing which is completed by 10 days. After healing, taper the drug and withdraw in 5 days. If after 7 days of initial therapy, there is no response, it means that virus is resistant to this drug. Hence change the drug and / or do mechanical debridement.
  • 13. Commonly used antiviral drugs are as follows- Acyclovir – 1. 3% ointment, 5 times a day until ulcer heals and then 3 times a day for 5 days. 2. It is least toxic and most commonly used antiviral drug. Ganciclovir - 1. 0.15% gel, 5 times a day until ulcer heals and then 3 times a day for 5 days. 2. It is more toxic than acyclovir.
  • 14. Triflurothymidine 1% drops, 2 hourly until ulcer heals and then 4 times a day for 5 days. Vidarabine 3% ointment, 5 times a day until ulcer heals and then 3 times a day for 5 days.
  • 15. Systemic antiviral drugs for a period of 10 to 21 days are used in recurrent and acute cases. Tb. Acyclovir 400 mg BD/ TID Tb. Famcyclovir 250 mg BD Tb. Valacyclovir 500 mg BD Non specific treatment- Same as earlier.
  • 16. Herpes Zoster Opthalmicus Systemic therapy for Herpes Zoster Oral antiviral drugs- Tb. Acyclovir 800 mg 5 times a day for 10 days or Tb. Valacyclovir 500 mg TID Analgesics- Pain during first 2 weeks of an attack is very severe and should be treated by combination of mephenamic acid and paracetamol or pentazocin or even pethidine (when very severe).
  • 17. Systemic Steroids- They inhibit development of post herpetic neuralgia when given in high doses. However, the risk of high doses of steroids in elders should be considered. They are commonly recommended in cases developing neurological complications such as third nerve palsy and optic neuritis. Cimetidine 300 mg QID for 2-3 weeks reduces pain and pruritis in acute zoster, by histamine blockade. Amitriptyline to relieve depression in acute phase.
  • 18. Local therapy for Herpes Zoster 1. For skin lesions- Antibiotic- steroid ointment or lotions-- three times a day till skin lesions heal. 2. For zoster keratitis- • Topical steroid eye drops 4 times a day. • Cycloplegics such as cyclopentolate eye drops or atropine eye ointment OD. • Topical acyclovir 3% eye ointment, 5 times a day for 2 weeks.
  • 19. 3. For secondary infections- Topical antibiotics 4. For secondary glaucoma- 0.5% timolol or betaxolol eye drops BD and Tb. Acetazolamide 250 mg QID. 5. For mucous plaques- Topical mucolytics like acetyl cysteine 5 to 10%, TID. 6. For persistent epithelial defects- Lubricating artificial tear drops.
  • 20. Protozoal Keratitis Acanthamoeba keratitis Specific treatment: Topical antiamoebic agents include- Diamidines: propamidine isethionate (0.1%), hexamidine (0.1%) Biguanides: polyhexamethylene biguanide (0.02%), chlorhexidine (0.02%) Aminoglycosides: neomycin, paromycin Imidazoles: clotrimazole and miconazole
  • 21. Multiple drug therapy is required for 3-4 months for early epithelial lesions and 6-12 months for stromal lesions.
  • 22. Allergic Keratitis Local therapy 1. Vasoconstrictors like adrenaline, ephedrine and naphazoline. 2. Topical steroids— Their use should be minimized as much as possible, because they frequently cause steroid induced glaucoma. Commonly used steroids are fluorometholone, medrysone, betamethasone or dexamethasone. First two are safest of all these.
  • 23. 3. Mast cell stabilizers such as sodium chromoglycate (2%) drops 4-5 times a day. 4. Topical antihistaminics- Azelastine eye drops 5. Acetyl cysteine (0.5%) has mucolytic properties and is useful in treating early plaque formation. 6. Topical cyclosporine (1%) drops effective in severe unresponsive cases. Systemic therapy- Oral antihistaminics and oral steroids in severe cases.
  • 24. Peripheral ulcerative keratitis associated with connective tissue disorders, Mooren’s Ulcer Topical medication with antibiotics, cycloplegics, steroids, lubricating drops. Systemic medication includes immunosuppresants (steroids, cyclosporine, cyclophosphamide), doxycycline and oral vitamin C.
  • 25. Rosacea Keratitis Topical treatment with steroids, but recurrences are very common. Systemic therapy— Most essential and effective treatment is long course of systemic tetracycline (250 mg QID for 3 weeks, TID for 3 weeks, BD for 3 weeks and OD for 3 months).
  • 26. Common ocular therapeutics Antibacterial agents Sulphonamides: 1. Bacteriostatic. 2. Act by inhibiting folic acid synthesis in susceptible microorganisms by competing with PABA which is essential for bacterial cell nutrition. 3. Used in treatment of chlamydial infections.
  • 27. Beta lactam antibiotics: Two important groups included are penicillins and cephalosporins. All of them act by interfering with synthesis of bacterial cell wall.
  • 28. Penicillins- Commonly used preparations are – Benzyl penicillin, procaine penicilln, ampicillin, amoxycillin. Methicillin, cloxacillin, flucloxacillin, carbenicillin---these are penicillinase resistant, useful in infections caused by staph, proteus, pseudomonas and coliform organisms.
  • 29. Cephalosporins- First generation (narrow spectrum)- 1. Active against gram positive cocci, hence useful against staphylococcus. 2. Includes---cefazolin, cephradine, cephalexin, cephadroxyl Second generation (intermediate spectrum)- 1. These have antistaphylococcal activity and are also effective against certain gram negative organisms. 2. These include—cefuroxime, cefoxitin, cefamandole. Third generation (wide spectrum)- 1. Mainly effective against gram negative organisms. 2. These include—cefotaxime, cefixime, cefotetan
  • 30. Aminoglycosides- Bactericidal. Primarily active against gram negative organisms. These are ototoxic and nephrotoxic.
  • 31. Aminoglycosides…….. Commonly used preparations are— Gentamicin- 1. Most commonly used aminoglycoside for acute infections, broader spectrum of action, effective against Pseudomonas aeruginosa. 2. Topically , it is used as 0.3% eye drops. Tobramycin- 1. More active against Pseudomonas and Proteus as compared to gentamicin. 2. Topically, it is used as 1% eye drops.
  • 32. Aminoglycosides…… Amikacin- It is recommended as reserve drug for hospital acquired infections with gram negative bacilli, where gentamicin resistance is increasing. Neomycin and Framycetin- 1. Wide spectrum of activity. 2. Active against most gram negative and some gram positive cocci. 3. Used only topically, due to high systemic toxicity.
  • 33. Tetracyclines and Chloramphenicol- 1. Broad spectrum bacteriostatic agents. 2. Active against gram positive, gram negative organisms as well as some fungi, Rickettsiae and Chlamydiae. 3. Topically used as 0.5 % eye drops.
  • 34. Polypeptides- 1. Bactericidal. 2. Includes polymyxin B, bacitracin, colistin. 3. Polymyxin B and colistin—active against most gram negative bacteria, notably Pseudomonas. 4. Neosporin (neomycin-polymyxin-bacitracin)—broad spectrum antimicrobial, but has a disadvantage of high incidence of sensitivity due to neomycin.
  • 35. Fluoroquinolones- 1. Broad spectrum of activity against gram positive and gram negative organisms. 2. Bactericidal drugs. Inhibit bacterial DNA synthesis. Commonly used are— 1. First generation—cipro, norfloxacin 2. Second generation– ofloxacin, lomefloxacin, pefloxacin. 3. Third generation– sparfloxacin 4. Fourth generation—gati, moxifloxacin
  • 36. Ocular antifungal agents Polyene antifungals- 1. Mainstay of antifungal therapy. 2. MOA—work by binding to the sterol groups in fungal cell membrane, making them impermeable. This leads to lethal imbalance in cell contents. 3. These include— Nystatin, natamycin, amphotericin B.
  • 37. Ocular antifungal agents…. Imidazole antifungal drugs- These include clotrimazole, econazole, fluconazole, miconazole, itraconazole. Other antifungals- Flucytosine Silver sulfadiazine—highly effective against Aspergillus and Fusarium species.
  • 38. Anti-glaucoma drugs for treating secondary glaucoma Timolol, Betaxolol- Class---beta blockers MOA---they block beta 2 receptors in the ciliary processess, resulting in decreased aqueous production, thus lowering the IOP. These drugs should be used cautiously in patients with bronchial asthma, emphysema, COPD, heart blocks, CCF and cardiomyopathy.
  • 39. Timolol, betaxolol……. Ocular side effects- Burning sensation, hyperemia, superficial punctate keratopathy, corneal anesthesia. Systemic side effects- CVS---result from blockade of beta 1 receptors. These include—bradycardia, arrhythmias, heart failure, syncope. RS---result from blockade of beta 2 receptors. These include—brnchospasm and airway obstruction, especially in asthmatics. Anti-glaucoma drugs for treating secondary glaucoma
  • 40. Timolol- 1. It is non selective beta 1 (cardiac) and beta 2 (smooth muscles, respiratory tract) blocker. 2. Available as 0.25 and 0.5% eye drops. 3. Its action starts within 30 minutes, peak reaches in 2 hours and effects last up to 24 hours. Hence, used once or twice daily. Anti-glaucoma drugs for treating secondary glaucoma
  • 41. Timolol….. 4. The phenomenon of “short term escape” and “long term drift” is seen with timolol. “Short term escape” implies marked initial fall in IOP, followed by a transient rise with continued moderate fall in IOP. “Long term drift” implies slow rise in IOP in patients who were well controlled with many months of therapy. Anti-glaucoma drugs for treating secondary glaucoma
  • 42. Betaxolol- 1. Is a cardioselective beta blocker, has 10 times more affinity for beta 1 receptors than beta 2 receptors. Hence, can be safely used in patients prone to attack of bronchial asthma; advantage over timolol. 2. Available as 0.5 % and 0.25% suspension, is used twice daily. 3. Action starts within 30 min, reaches peak in 2 hours and lasts for 12 hours. 4. Slightly less effective than timolol in lowering IOP. Anti-glaucoma drugs for treating secondary glaucoma
  • 43. Anti-glaucoma drugs for treating secondary glaucomaAcetazolamide- 1. Is a carbonic anhydrase inhibitor. 2. Lowers IOP by reducing formation of aqueous humour. 3. Used as additive therapy for short term in management of all types of acute and chronic glaucomas. 4. Side effects—paresthesias, urinary frequency, serum electrolyte imbalance, abdominal discomfort, nausea, diarrhoea.
  • 44. Anti-glaucoma drugs for treating secondary glaucomaAcetazolamide…. 4. Available as tablets, capsules and injection for i.v. use. 250 mg tablet is used 6 hourly. 5. Action starts within one hour, reaches peak in 4 hours and lasts for 6-8 hours. Other carbonic anhydrase inhibitors— Dorzolamide, Brinzolamide—can be used topically.
  • 45. Anti-glaucoma drugs for treating secondary glaucomaMannitol, Glycerol- 1. These are hyperosmotic agents, administered systemically. 2. Used as additive therapy for rapidly lowering IOP in emergency situations. 3. MOA– they increase the plasma tonicity. Thus, osmotic gradient created between blood and vitreous draws sufficient water out of the eyeball, thereby lowering IOP.
  • 46. Anti-glaucoma drugs for treating secondary glaucomaGlycerol- 1. Dose-1 to 1.5 gm/kg 2. Action starts in 10 minutes, peaks in 30 minutes and lasts for about 5-6 hours. 3. It is metabolised to glucose in the body, hence repeated use is not recommended in diabetics.
  • 47. Anti-glaucoma drugs for treating secondary glaucomaMannitol- 1. Dose-1-2 gm/kg 2. Administered very rapidly over 20-30 minutes. 3. Action peaks in 30 minutes and lasts for about 6 hours. 4. It doesn’t enter glucose metabolism, hence safe in diabetics.
  • 48. Corticosteroids They have potent anti-inflammatory, anti-allergic and anti- fibrotic actions. Short acting- Hydrocortisone, cortisone, prednisolone, methylprednisolone, prednisone. Intermediate acting- Triamcinolone, fluprednisolone Long acting- Dexamethasone, betamethasone.
  • 49. Corticosteroids ……. Commonly used topical preparations are cortisone acetate, hydrocortisone, dexamethasone, betamethas one, medryson, fluromethalone, loteprednol. Commonly used systemic preparations are – Prednisolone—5 / 10 mg tablet, Dexamethasone– 0.5 mg tablet, Betamethasone– 0.5 / 1 mg tablet.
  • 50. Corticosteroids ……. Side effects- Injudicious use of topical steroids can cause glaucoma, cataract, activation of infection (if given in herpertic, fungal or bacterial keratitis), dry eye, ptosis. Misuse of systemic steroids can cause ocular side effects as mentioned above and systemic side effects such as peptic ulcer, HTN, osteoporosis, worsening of DM, cushingoid state and reactivation of tuberculosis and other infections.
  • 51. Non steroidal anti-inflammatory drugs (NSAIDs) They have anti-inflammatory, analgesic and antipyretic actions. MOA– act by irreversibly blocking COX enzyme, thus inhibiting PG synthesis. Also block other local mediators of inflammatory response.
  • 52. Non steroidal anti-inflammatory drugs (NSAIDs)………… Topical opthalmic NSAIDs preparations available are- 1. Indomethacin 0.1 % suspension 2. Flurbiprofen 0.3 % eye drops 3. Ketorolac 0.5 % eye drops 4. Diclofenac 0.1% eye drops 5. Bromefenac 0.09% eye drops 6. Nepafenac 0.1 % eye drops Systemically used NSAIDs- Paracetamol, diclofenac, acelcofenac, ketorolac, ibuprofen flurbiprofen, naproxen, mefenamic acid, etc.
  • 53. Cycloplegics These are the drugs which cause paralysis of accommodation and dilatation of the pupil. Commonly used drug is atropine sulfate 1% eye ointment or drops instilled 2-3 times a day. In case of atropine allergy, other cycloplegics like 2% homatropine or 1% cyclopentolate (short acting) eye drops may be instilled 3-4 times/ day. Alternatively for more cycloplegic effect, a subconjunctival injection of 0.25 ml mydricain (mixture of atropine, adrenaline and procaine) can be given.
  • 54. Cycloplegics…… Mode of action of atropine- 1. Gives comfort and rest to the eye by relieving spasm of iris sphincter and ciliary muscle. 2. Prevents formation of synechiae and may break already formed synechiae. 3. Reduces exudation by decreasing hyperemia and vascular permeability. 4. Increases blood supply to anterior uvea by relieving pressure on anterior ciliary arteries. As a result more antibodies reach the target tissue and more toxins are absorbed.